Increased oxidative stress in obesity and its impact on metabolic syndrome

Journal of Clinical Investigation

Volumn 114, Issue 12, 2004, Pages 1752-1761

  Furukawa, Shigetada ^a   Fujita, Takuya ^a   Shimabukuro, Michio ^b   Iwaki, Masanori ^a   Yamada, Yukio ^a   Nakajima, Yoshimitsu ^c   Nakayama, Osamu ^c   Makishima, Makoto ^a,f   Matsuda, Morihiro ^a,e   Shimomura, Iichiro ^a,d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c ASTELLAS PHARMA INC   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ANTIOXIDANT; CYTOKINE; HYDROGEN PEROXIDE; MESSENGER RNA; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ADIPOCYTE; ANIMAL; BIOLOGICAL MODEL; BODY WEIGHT; C57BL MOUSE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; IMMUNOBLOTTING; LIPID PEROXIDATION; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MOUSE MUTANT; OXIDATION REDUCTION REACTION; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; AGED; ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CELL DIFFERENTIATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROGEN PEROXIDE; IMMUNOBLOTTING; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, OBESE; MIDDLE AGED; MODELS, BIOLOGICAL; NADPH OXIDASE; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 85030434746     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI21625     Document Type: Article

References (66)

1. Isomaa, B., et al. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24:683-689.
2. Ford, E.S., Giles, W.H., and Dietz., W.H. 2002. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 287:356-359.
3. Grundy, S.M., et al. 2004. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 109:433-438.
4. Montague, C.T., and O'Rahilly, S. 2000. The perils of portliness: causes and consequences of visceral adiposity. Diabetes. 49:883-888.
5. Matsuzawa, Y., Funahashi, T., and Nakamura, T. 1999. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Ann. N. Y. Acad. Sci. 892:146-154.
6. Spiegelman, B.M., and Flier, J.S. 2001. Obesity and the regulation of energy balance. Cell. 104:531-543.
7. Kahn, B.B., and Flier, J.S. 2000. Obesity and insulin resistance. J. Clin. Invest. 106:473-481.
8. Friedman, J.M. 2000. Obesity in the new millennium. Nature. 404:632-634.
9. Saltiel, A.R., and Kahn, C.R. 2001. Insulin signaling and the regulation of glucose and lipid metabolism. Nature. 414:799-806.
10. Shimomura, I., et al. 1996. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 2:800-803.
11. Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. 1993. Adipose expression of rumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 259:87-91.
12. Uysal, K.T., Wiesbrock, S.M., Marino, M.W., and Hotamisligil, G.S. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 389:610-614.
13. Steppan, C.M., et al. 2001. The hormone resistin links obesity to diabetes. Nature. 409:307-312.
14. Banerjee, R.R., et al. 2004. Regulation of fasted blood glucose by resistin. Science. 303:1195-1198.
15. Friedman, J.M., and Halaas, J.L. 1998. Leptin and the regulation of body weight in mammals. Nature. 395:763-770.
16. Farooqi, I.S., et al. 2001. Partial leptin deficiency and human adiposity. Nature. 414:34-35.
17. Unger, R.H. 2003. The physiology of cellular lipo-regulation. Annu. Rev. Physiol. 65:333-347.
18. Berg, A.H., Combs, T.P., and Scherer, P.E. 2002. ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13:84-89.
19. Tsao, T.S., Lodish, H.F., and Fruebis, J. 2002. ACRP30, a new hormone controlling fat and glucose metabolism. Eur. J. Pharmacol. 440:213-221.
20. Matsuzawa, Y., Funahashi, T., Kihara, S., and Shimomuta, I. 2004. Adiponectin and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 24:29-33.
21. Atita, Y., et al. 1999. Patadoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257:79-83.
22. Fruebis, J., et al. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U. S. A. 98:2005-2010.
23. Yamauchi, T, et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:941-946.
24. Berg, A.H., Combs, T.P., Du, X., Brownlee, M., and Scherer, P.E. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7:947-953.
25. Maeda, N., et al. 2002. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8:731-737.
26. Okamoro, Y., et al. 2002. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 106:2767-2770.
27. Matsuda, M., et al. 2002. Role of adiponectin in preventing vascular stenosis. The missing link of adipovascular axis. J. Biol. Chem. 277:37487-37491.
28. Yamauchi, T., et al. 2003. Globular adiponectin protected ob/ob mice from diabetes and apoE-deficient mice from atherosclerosis. J. Biol. Chem. 278:2461-2468.
29. Brownlee, M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature. 414:813-820.
30. Maddux, B.A., et al. 2001. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes. 50:404-410.
31. Rudich, A., et al. 1998. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes. 47:1562-1569.
32. Matsuoka, T., et al. 1997. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest. 99:144-150.
33. Nakazono, K.,et al. 1991. Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. U. S. A. 88:10045-10048.
34. Ohara, Y., Peterson, T.E., and Harrison, D.G. 1993. Hypercholesterolemia increases endothelial superoxide anton production. J. Clin. Invest. 91:2546-2551.
35. Oliveira, H.R., et al. 2003. Pancreatic β-cells express phagocyte-like NAD(P)H oxidase. Diabetes. 52:1457-1463.
36. Griendling, K.K., Sorescu, D., and Ushio-Fukai, M. 2000. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86:494-501.
37. Li, S., Valente, A.J., Zhao, S., and Clark, R.A. 1997. PU.1 is essential for p47phox promoter activity in myeloid cells. J. Biol. Chem. 272:17802-17809.
38. Nishikawa,T., et al. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 404:787-790.
39. Inoguchi, T., et al. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 49:1939-1945.
40. Iwaki, M., et al. 2003. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes. 52:1655-1663.
41. Simons, J.M., Hart, B.A., Ip Vai Ching, T.R., Van Dijk, H., and Labadie, R.P. 1990. Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radic. Biol. Med. 8:251-258.
42. Meyer, J.W., et al. 1990. Identification of a function leukocyte-type NADPH oxidase in human endothelial cells: a potential atherogenic source of reactive oxygen species. Endothelium. 7:11-22.
43. Beswick, R.A., Dorrance, A.M., Leite, R., and Webb, R.C. 2001. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 38:1107-1111.
44. Cotter, M.A., and Cameron, N.E. 2003. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci. 73:1813-1824.
45. Fried, S.K., Bunkin, D.A., and Greenberg, A.S. 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83:847-850.
46. Sartipy, P., and Loskutoff, D.J. 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 100:7265-7270.
47. Hainault, I., et al. 2002. Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) zucker rat. Am. J. Physiol. Endocrinol Metab. 282:E59-E66.
48. Keaney, J.F., Jr., et al. 2003. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler. Thromb. Vasc. Biol. 23:434-439.
49. Olusi, S.O. 2002. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotective enzymes in humans. Int. J. Obes. Relat. Metab. Disord. 26:1159-1164.
50. Shibuya, A., et al. 2002. Nitration of PPARγ inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264. FEBS Lett. 525:43-47.
51. Roskams, T., et al. 2003. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am. J. Pathol. 163:1301-1311.
52. Weisberg, S.P., et al. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:1796-1808. doi: 10.1172/JCI200319246.
53. Xu, H., et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112:1821-1830. doi: 10.1172/JCI200319451.
54. Shiose, A., et al. 2001. A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 276:1417-1423.
55. Suh, Y.A., et al. 1999. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 401:79-82.
56. 2 and plays an integral role in insulin signal transduction. Mol Cell Biol. 24:1844-1854.
57. Yang, S., Zhang, Y., Ries, W., and Key, L. 2004. Expression of Nox4 in osteoclasts. J. Cell. Biochem. 92:238-248.
58. Sorescu, D., et al. 2002. Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation. 105:1429-1435.
59. Curzio, M., et al. 1987. Possible role of aldehydic lipid peroxidation products as chemoattractants. Int. J. Tissue React. 9:295-306.
60. Tirosh, A., Potashnik, R., Bashan, N., and Rudich, A. 1999. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J. Biol. Chem. 274:10595-10602.
61. Jacob, S., et al. 1999. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic. Biol. Med. 27:309-314.
62. Evans, J.L., Goldfine, I.D., Maddux, B.A., and Grodsky, G.M. 2002. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocrine Rev. 23:599-622.
63. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J. Clin. Invest. 89:1006-1013.
64. 2 generation in 3T3-L1 cells. Biochem. J. 307:549-556.
65. Takahashi, K. 2000. Glutathione peroxidase: coupled enzyme assay. In Experimental protocols for reactive oxygen and nitrogen species. N. Taniguchi and J.M.C. Gutteridge, editors. Oxford University Press. Oxford, United Kingdom. 79-80.
66. Yokode, M., Hammer, R.E., Ishibashi, S., Brown, M.S., and Goldstein, J.L. 1990. Diet-induced hypercholesterolemia in mice: prevention of overexpression of LDL receptors. Science. 250:1273-1275.